How the BaselArea.swiss-App connects innovators and supports an innovative idea.
One of the major assets of BaselArea.swiss is its broad network, which has been confirmed...
The bad news: If anyone expected that Behavioral Sciences will soon lead to a nudge strategy to solve every one of Healthcare’s problems then they were disappointed at the ...
BC Platforms is developing a digital platform to offer genomic and clinical data. This platform is now being integrated in Google Cloud. Pharmaceutical companies and hospitals wi...
DayOne Experts Event Report - The Swiss Personalized Health Network (SPHN) – making Switzerland a hot bed for research in Precision Medicine and Personalized Health
The “Digital Biomarkers in Clinical Trials Summit” is the first global forum of its kind to focus on ways for pharma clinical trials to take advantage of new opp...
We had the great honour to join this year’s Innovation factory at MSD (Merck & Co) as keynote speakers and members of the Jury.
It was an opportunity for us to ...
After 20 years with the pharmaceutical company Eli Lilly, Bernard Munos set out to better understand pharmaceutical innovation – specifically what makes it possible and how...
The last DayOne Experts event of 2017 had over 90 participants who came to hear about disruption in healthcare insurance and both how it affects the Pharma industry and how toget...
A new app developed by the Basel pharmaceutical company Novartis is set to revolutionize ophthalmology clinical trials by allowing patients to self-record some of their data. Nov...
Most new technologies are over-rated in the short term, but under-rated in the long term. Will Artifical Intelligence (AI) in healthcare follow this trend?
With great hyp...
In April, Ian Rentsch will take over as CEO of Clinerion, a Basel-based startup that runs a platform for recruiting patients for clinical trials. Rentsch sees major potential for...
THE EVENT IS ALREADY FULLY BOOKED.
BaselArea.swiss is exited to invite you to the first “Bas...
BC Platforms, a world leader in genomic data management and analytics, has developed GeneVision as a new solution to facilitate data handling in precision medicine. The Basel-bas...
The Basel-based pharmaceutical company Novartis has entered into a collaboration with the U.S. firm Pear Therapeutics. The aim is to develop digital therapies to treat patients w...
